Solvay remains a buy, supported by strong market leadership, resilient cash generation, and a secure 9% dividend yield. SVYSF faces headwinds from weak macroeconomic trends, tariff uncertainties, and ...
The dental market is sluggish, with higher out-of-pocket costs driving sluggish volumes and trading-down for this macro-sensitive segment of healthcare. Dentsply Sirona Inc. is seeing these trends ...